Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$13.80
$13.79
$6.47
$14.22
$706.97M1.261.05 million shs1.38 million shs
GRAIL, Inc. stock logo
GRAL
GRAIL
$64.59
+5.7%
$60.03
$29.95
$118.84
$2.62B3.15843,140 shs642,430 shs
Progyny, Inc. stock logo
PGNY
Progyny
$26.89
+1.0%
$23.02
$16.10
$28.75
$2.09B1.031.49 million shs898,329 shs
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$15.22
+4.7%
$14.09
$11.41
$24.10
$1.90B1.961.24 million shs1.06 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
0.00%0.00%0.00%+0.99%+48.87%
GRAIL, Inc. stock logo
GRAL
GRAIL
-1.59%+4.84%-9.05%+16.87%+41.89%
Progyny, Inc. stock logo
PGNY
Progyny
+1.33%+0.11%+7.03%+50.03%+28.09%
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
-0.14%-4.03%+8.43%+20.58%-28.07%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Enhabit, Inc. stock logo
EHAB
Enhabit
$13.80
$13.79
$6.47
$14.22
$706.97M1.261.05 million shs1.38 million shs
GRAIL, Inc. stock logo
GRAL
GRAIL
$64.59
+5.7%
$60.03
$29.95
$118.84
$2.62B3.15843,140 shs642,430 shs
Progyny, Inc. stock logo
PGNY
Progyny
$26.89
+1.0%
$23.02
$16.10
$28.75
$2.09B1.031.49 million shs898,329 shs
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$15.22
+4.7%
$14.09
$11.41
$24.10
$1.90B1.961.24 million shs1.06 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Enhabit, Inc. stock logo
EHAB
Enhabit
0.00%0.00%0.00%+0.99%+48.87%
GRAIL, Inc. stock logo
GRAL
GRAIL
-1.59%+4.84%-9.05%+16.87%+41.89%
Progyny, Inc. stock logo
PGNY
Progyny
+1.33%+0.11%+7.03%+50.03%+28.09%
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
-0.14%-4.03%+8.43%+20.58%-28.07%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Enhabit, Inc. stock logo
EHAB
Enhabit
2.11
Hold$13.57-1.66% Downside
GRAIL, Inc. stock logo
GRAL
GRAIL
2.30
Hold$67.003.73% Upside
Progyny, Inc. stock logo
PGNY
Progyny
2.79
Moderate Buy$29.9211.26% Upside
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
2.75
Moderate Buy$22.1845.74% Upside

Current Analyst Ratings Breakdown

Latest EHAB, GRAL, PGNY, and SGRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/22/2026
Progyny, Inc. stock logo
PGNY
Progyny
Boost Price TargetBuy$30.00 ➝ $33.00
6/5/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Initiated CoverageNeutral$60.00
6/5/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Initiated CoverageNeutral$60.00
6/5/2026
Progyny, Inc. stock logo
PGNY
Progyny
DowngradeStrong-BuyHold
6/4/2026
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
UpgradeHoldStrong-Buy
6/2/2026
GRAIL, Inc. stock logo
GRAL
GRAIL
Initiated CoveragePeer Perform
6/2/2026
Progyny, Inc. stock logo
PGNY
Progyny
Boost Price TargetBuy$29.00 ➝ $31.00
5/26/2026
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
Reiterated RatingSell (E+)
5/19/2026
Progyny, Inc. stock logo
PGNY
Progyny
UpgradeHoldBuy$19.00 ➝ $30.00
5/15/2026
Progyny, Inc. stock logo
PGNY
Progyny
Boost Price TargetOverweight$23.00 ➝ $27.00
5/11/2026
Progyny, Inc. stock logo
PGNY
Progyny
Reiterated RatingOutperform
(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Enhabit, Inc. stock logo
EHAB
Enhabit
$1.06B0.67$1.96 per share7.04$11.30 per share1.22
GRAIL, Inc. stock logo
GRAL
GRAIL
$147.17M18.84N/AN/A$66.13 per share0.98
Progyny, Inc. stock logo
PGNY
Progyny
$1.29B1.63$0.74 per share36.17$5.99 per share4.49
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
$3.31B0.60$1.79 per share8.51$24.21 per share0.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Enhabit, Inc. stock logo
EHAB
Enhabit
-$4.60M-$0.09N/A21.56N/A-0.30%7.24%3.48%8/5/2026 (Estimated)
GRAIL, Inc. stock logo
GRAL
GRAIL
-$408.35M-$10.37N/AN/AN/A-253.22%-16.42%-14.34%8/11/2026 (Estimated)
Progyny, Inc. stock logo
PGNY
Progyny
$58.52M$0.7734.9223.182.355.23%13.34%9.03%8/6/2026 (Estimated)
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
-$77.90M-$0.60N/A43.494.34-2.28%1.04%0.41%8/4/2026 (Estimated)

Latest EHAB, GRAL, PGNY, and SGRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A$0.36N/A$0.36N/A$264.80 million
5/7/2026Q1 2026
Progyny, Inc. stock logo
PGNY
Progyny
$0.2560$0.50+$0.2440$0.29$326.47 million$328.50 million
5/5/2026Q1 2026
GRAIL, Inc. stock logo
GRAL
GRAIL
-$2.7629-$2.29+$0.4729-$2.29$39.16 million$40.79 million
5/5/2026Q1 2026
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
-$0.15-$0.03+$0.12-$0.28$797.69 million$810.90 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Enhabit, Inc. stock logo
EHAB
Enhabit
N/AN/AN/AN/AN/A
GRAIL, Inc. stock logo
GRAL
GRAIL
N/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Enhabit, Inc. stock logo
EHAB
Enhabit
0.70
1.56
1.56
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
11.74
11.74
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.13
2.13
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
1.17
1.86
1.69

Institutional Ownership

CompanyInstitutional Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
N/A
GRAIL, Inc. stock logo
GRAL
GRAIL
N/A
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
N/A

Insider Ownership

CompanyInsider Ownership
Enhabit, Inc. stock logo
EHAB
Enhabit
3.40%
GRAIL, Inc. stock logo
GRAL
GRAIL
1.83%
Progyny, Inc. stock logo
PGNY
Progyny
9.90%
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
2.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Enhabit, Inc. stock logo
EHAB
Enhabit
10,80051.23 million49.48 millionOptionable
GRAIL, Inc. stock logo
GRAL
GRAIL
1,36042.92 million42.13 millionOptionable
Progyny, Inc. stock logo
PGNY
Progyny
31078.33 million70.58 millionOptionable
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
16,000130.79 million128.17 millionOptionable

Recent News About These Companies

5 Best Small Cap Stocks to Buy for 10x Potential
Surgery Partners: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Enhabit stock logo

Enhabit NYSE:EHAB

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.

GRAIL stock logo

GRAIL NASDAQ:GRAL

$64.59 +3.48 (+5.70%)
Closing price 03:59 PM Eastern
Extended Trading
$63.44 -1.15 (-1.78%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Progyny stock logo

Progyny NASDAQ:PGNY

$26.89 +0.26 (+0.98%)
Closing price 04:00 PM Eastern
Extended Trading
$26.70 -0.19 (-0.69%)
As of 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Surgery Partners stock logo

Surgery Partners NASDAQ:SGRY

$15.22 +0.69 (+4.75%)
Closing price 04:00 PM Eastern
Extended Trading
$15.22 0.00 (0.00%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.